Jan Holgersson

Idogen strengthens the Board with Jan Holgersson

Idogen strengthens the Board of Directors with Professor Jan Holgersson, who has extensive experience in immunology and who has been a member of the...
Mikeael Lindstam, Aptahem

Aptahem’s CEO on upcoming milestones

Aptahem has taken several steps forward in 2022. Recently, the biotech company passed a milestone with the start of the clinical phase I study...
CLS vd Dan Mogren i BioStocks studio i Lund

CLS on a Q3 characterised by US-advancement

Medtech Clinical Laserthermia Systems, CLS, can look back on a third quarter characterised by advancement on the US market. In September, the company received...

PHI on the alliance for cell-based biomanufacturing

Phase Holographic Imaging, PHI, recently created a US-based alliance for advancing cell-based biomanufacturing with Wake Forest Institute for Regenerative Medicine, BioSpherix, QIAGEN and global...
Elicera iTANK partnering intensifies

Elicera’s CEO: “iTANK partnering is intensifying”

Elicera Therapeutics is in an advantageous position, both in terms of financial flexibility and the ability to enter into new collaboration agreements. The cell...
IBS behandling

IBS treatment – a breakthrough around the corner?

Approximately one billion people worldwide live with IBS, a condition that often has a major impact on life. Despite this fact, effective drugs against...
Neola Medical has been ISO certified

Neola Medical receives ISO certification

Neola Medical is working hard towards the goal of obtaining market approval in the US with Neola, the company's product for monitoring the lungs...
BioInvent - FDA

Regulatory success for BioInvent in the US

The U.S. Food and Drug Administration has approved BioInvent's Investigational New Drug application for the antibody BI-1607, which is being developed to enhance efficacy...
Anders Weilandt

Chordate Medical reports Q3 and carries out rights issue

Medtech company Chordate Medical has published the report for the third quarter where they particularly highlight the completion of the migraine study. Strengthened by...
IBS an undertreated market

IBS – an undertreated condition

With a prevalence of 11 per cent, IBS is considered one of the world's most common conditions. Although innocuous, it significantly impacts the sufferer's...